標(biāo)題: Titlebook: Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends; Mark A. Giembycz,Brian J. O’Connor Book 2000 Springer Basel AG 2000 Atm [打印本頁(yè)] 作者: 決絕 時(shí)間: 2025-3-21 16:18
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends影響因子(影響力)
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends被引頻次
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends被引頻次學(xué)科排名
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends年度引用
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends年度引用學(xué)科排名
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends讀者反饋
書(shū)目名稱(chēng)Asthma: Epidemiology, Anti-Inflammatory Therapy and Future Trends讀者反饋學(xué)科排名
作者: ORBIT 時(shí)間: 2025-3-21 22:38 作者: 從容 時(shí)間: 2025-3-22 03:30
Book 2000thod of induced sputum examination. 1. 2. Why Is Assessment of Airway Inflammation Important in Asthma? Inflammation is a localized protective response elicited by injury or destruc- tion of tissues which serves to destroy, dilute or wall off both the injurious agent and the injured tissue [2]. The 作者: 圓錐 時(shí)間: 2025-3-22 04:40
direct method of induced sputum examination. 1. 2. Why Is Assessment of Airway Inflammation Important in Asthma? Inflammation is a localized protective response elicited by injury or destruc- tion of tissues which serves to destroy, dilute or wall off both the injurious agent and the injured tissue [2]. The 978-3-0348-9585-9978-3-0348-8480-8作者: meditation 時(shí)間: 2025-3-22 10:26
Epidemiology of Asthma Mortality,y throughout the 20th century, focusing primarily on the possible causes for the mortality epidemics and the gradual rise in asthma mortality which has occurred over recent decades. Finally, we review markers of an increased risk of asthma mortality, the characteristics of patients experiencing a fa作者: 聲明 時(shí)間: 2025-3-22 16:23
Epidemiology of Childhood Asthma,iagnosis of bronchitis or of asthma differed from healthy controls with respect to family and personal history of allergic disease and personal atopy [1], that some children with the diagnosis of wheezy bronchitis responded positively to asthmatic therapy [2], and that children were more likely to b作者: 加入 時(shí)間: 2025-3-22 21:04
,Is Chronic Use of β2-Agonists Detrimental in the Treatment of Asthma?,ical manifestations of asthma Surprisingly, this occurred in the absence of any substantial controlled clinical trials demonstrating their long-term efficacy or safety. A 1-week crossover trial of four times daily versus as-needed inhalation of salbutamol in 18 patients whose evening peak flow rates作者: mastoid-bone 時(shí)間: 2025-3-22 21:54
Formeln und Fakten im Grundkurs Mathematiky throughout the 20th century, focusing primarily on the possible causes for the mortality epidemics and the gradual rise in asthma mortality which has occurred over recent decades. Finally, we review markers of an increased risk of asthma mortality, the characteristics of patients experiencing a fa作者: 適宜 時(shí)間: 2025-3-23 02:38 作者: falsehood 時(shí)間: 2025-3-23 07:32
Formeln und Fakten im Grundkurs Mathematikical manifestations of asthma Surprisingly, this occurred in the absence of any substantial controlled clinical trials demonstrating their long-term efficacy or safety. A 1-week crossover trial of four times daily versus as-needed inhalation of salbutamol in 18 patients whose evening peak flow rates作者: 致命 時(shí)間: 2025-3-23 12:04 作者: 他去就結(jié)束 時(shí)間: 2025-3-23 15:59 作者: Judicious 時(shí)間: 2025-3-23 21:59 作者: 伴隨而來(lái) 時(shí)間: 2025-3-23 23:46 作者: 不能根除 時(shí)間: 2025-3-24 02:23
Theophylline and New Generation Phosphodiesterase Inhibitors in the Treatment of Asthma,duced for the treatment of asthma, and this decline has come about mainly due to concerns about the narrow therapeutic window of theophylline, which has typically been classified as being 10-20.μg/ml in plasma [1].作者: Spinal-Fusion 時(shí)間: 2025-3-24 08:44 作者: 花爭(zhēng)吵 時(shí)間: 2025-3-24 13:47 作者: 痛打 時(shí)間: 2025-3-24 18:39 作者: archenemy 時(shí)間: 2025-3-24 21:43
https://doi.org/10.1007/978-3-662-25776-0th mild, moderate and severe asthma. Our knowledge about the use of inhaled corticosteroids and other drugs in children ≤3 years is more limited. Therefore, recommendations about pharmacological asthma management in the ≤3 age group are based upon less evidence than the recommendations for older children.作者: 印第安人 時(shí)間: 2025-3-24 23:14
Die hypergeometrische Funktion, of three cysteinyl leukotriene receptor antagonists, montelukast, zafirlukast and pranlukast, and one inhibitor of leukotriene synthesis, zileuton, which are available in many countries round the world.作者: 原始 時(shí)間: 2025-3-25 04:56
Wilhelm Magnus,Fritz Oberhettinger at that time described benefit in chronic asthma [4], demonstrating the unequivocal benefit of corticosteroids in asthma. Subsequently, both oral and inhaled corticosteroids have evolved into the most important and useful drugs currently available to treat asthma作者: overwrought 時(shí)間: 2025-3-25 11:09 作者: moribund 時(shí)間: 2025-3-25 13:14 作者: mitral-valve 時(shí)間: 2025-3-25 19:34
Wilhelm Magnus,Fritz OberhettingerWith the increasing awareness of the importance of inflammation in the pathogenesis of asthma even in relatively mild patients [1], more and more emphasis is being put on anti-inflammatory approaches to treatment.作者: ALE 時(shí)間: 2025-3-25 22:36 作者: judicial 時(shí)間: 2025-3-26 03:38 作者: expound 時(shí)間: 2025-3-26 06:05
Steroid Sparing Therapies in Asthma,The recognition that asthma is a consequence of airway inflammation has focused treatment goals towards anti-inflammatory agents. Inhaled and systemic corticosteroids are of proven benefit and inhaled steroids are so effective that systemic corticosteroids are usually reserved for acute exacerbations of the condition.作者: mechanism 時(shí)間: 2025-3-26 11:19 作者: Venules 時(shí)間: 2025-3-26 13:21
https://doi.org/10.1007/978-3-663-12119-0accepted epidemiological definition of the condition. Existing definitions of asthma in adults are more descriptive than definitive, focussing on the clinical characteristics of reversible airways obstruction, chronic airway inflammation, and increased bronchial responsiveness to a variety of stimul作者: gentle 時(shí)間: 2025-3-26 18:44 作者: entail 時(shí)間: 2025-3-26 22:04
,Grenzf?lle der Functionen ?, and ?,,a high level of reliability and accuracy, be safe, acceptable to the patient, easy to perform and non-invasive. The latter demands that the technique should not break the skin or the lining epithelium and should be devoid of effects on the tissues of the body by the dissipation of energy or the intr作者: 名詞 時(shí)間: 2025-3-27 04:57
https://doi.org/10.1007/978-3-662-25776-0s obtained through controlled clinical trials in patients of a similar age and disease severity as the group in which the drug is being considered for use. Abundant, high quality clinical efficacy and safety data have been obtained on the use of inhaled corticosteroids in children >3 years of age wi作者: 顯微鏡 時(shí)間: 2025-3-27 09:14
Wilhelm Magnus,Fritz Oberhettingerrted the benefits of oral cortisone on ragweed pollen-induced hay fever and asthma. This was followed by a report by Gelfand [2], demonstrating clinical benefit from inhaled cortisone in a small group of patients with both allergic or non-allergic asthma. Subsequently, a multicenter trial run by the作者: infarct 時(shí)間: 2025-3-27 12:10 作者: deficiency 時(shí)間: 2025-3-27 15:00 作者: Hectic 時(shí)間: 2025-3-27 19:24 作者: Virtues 時(shí)間: 2025-3-28 00:11
978-3-0348-9585-9Springer Basel AG 2000作者: 本能 時(shí)間: 2025-3-28 03:37 作者: Annotate 時(shí)間: 2025-3-28 07:46 作者: JADED 時(shí)間: 2025-3-28 14:12
,Is Chronic Use of β2-Agonists Detrimental in the Treatment of Asthma?,enging the wisdom of regular use of the short-acting β.-agonists which traditionally have formed the mainstay of treatment for bronchial asthma [1–5]. Although all national and international guidelines for the management of asthma now rec-ommend anti-inflammatory therapy for most patients with chron作者: 向外才掩飾 時(shí)間: 2025-3-28 14:43
Assessment of Airway Inflammation in Asthma Using Non-Invasive Methods,a high level of reliability and accuracy, be safe, acceptable to the patient, easy to perform and non-invasive. The latter demands that the technique should not break the skin or the lining epithelium and should be devoid of effects on the tissues of the body by the dissipation of energy or the intr作者: Dungeon 時(shí)間: 2025-3-28 20:20
Treatment of Asthma in Children: the Case for Inhaled Corticosteroids as First Line Agents,s obtained through controlled clinical trials in patients of a similar age and disease severity as the group in which the drug is being considered for use. Abundant, high quality clinical efficacy and safety data have been obtained on the use of inhaled corticosteroids in children >3 years of age wi作者: Obstacle 時(shí)間: 2025-3-28 23:04
Future Trends in the Use of Corticosteroids in Asthma,rted the benefits of oral cortisone on ragweed pollen-induced hay fever and asthma. This was followed by a report by Gelfand [2], demonstrating clinical benefit from inhaled cortisone in a small group of patients with both allergic or non-allergic asthma. Subsequently, a multicenter trial run by the作者: chlorosis 時(shí)間: 2025-3-29 03:49
